What is the appropriate treatment for amlodipine and atenolol overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Amlodipine and Atenolol Overdose

For combined amlodipine and atenolol poisoning causing life-threatening hypotension or bradycardia, immediately initiate high-dose insulin euglycemia therapy (1 unit/kg/hour bolus, then 0.5-1 unit/kg/hour infusion) along with vasopressors (norepinephrine preferred), and consider early hemodialysis specifically for atenolol removal given its hydrophilic properties. 1

Initial Stabilization and Decontamination

Start with aggressive supportive care:

  • Airway protection if altered mental status is present
  • Gastric lavage if presenting within 1-2 hours of ingestion
  • Activated charcoal (if airway protected and no contraindications)
  • Whole bowel irrigation may be considered for sustained-release formulations
  • Aggressive IV crystalloid resuscitation - but monitor closely for pulmonary edema, which can develop even with modest fluid volumes 2

Critical pitfall: Amlodipine has a long half-life (30-50 hours) and delayed onset of toxicity, so patients require extended monitoring even if initially stable. Effects may worsen over 6-12 hours post-ingestion.

Pharmacologic Management Algorithm

First-Line Therapy (Class I Recommendations)

1. High-Dose Insulin Euglycemia Therapy (HIET) 1

  • Bolus: 1 unit/kg regular insulin IV
  • Infusion: 0.5-1 unit/kg/hour, titrate up to 10 units/kg/hour if needed 3
  • Concurrent dextrose: Start 0.5 g/kg/hour (D10W or D50W), adjust to maintain euglycemia
  • Monitoring: Blood glucose every 15-30 minutes initially, then hourly; potassium every 2-4 hours
  • Rationale: Improves myocardial contractility and has lower vasoconstrictive complications than vasopressors alone for both CCB and beta-blocker toxicity

Important: One case series showed dramatic improvement only occurred at maximum insulin doses (10 units/kg/hour), not at conventional 4 units/kg/hour 3. Don't hesitate to escalate rapidly.

2. Vasopressors 1

  • Norepinephrine is preferred (doses up to 100 μg/min may be required)
  • Start early - readily available and act quickly
  • May require multiple agents (norepinephrine + epinephrine + vasopressin)

Second-Line Therapies (Class IIa Recommendations)

3. Calcium Salts 1

  • Calcium chloride 10%: 10-20 mL (1-2 g) IV bolus, repeat every 15-20 minutes
  • Continuous infusion: 0.2-0.4 mL/kg/hour calcium chloride 10%
  • Target: Ionized calcium up to 2× normal may be more effective than lower doses 1
  • Note: Most patients require additional therapies beyond calcium alone

4. Glucagon 1

  • Bolus: 3-5 mg IV (or 0.05-0.15 mg/kg)
  • Infusion: 2-10 mg/hour
  • Limitations: Variable response rates, common vomiting, rapid tachyphylaxis
  • Practical issue: Often unavailable 4

5. Atropine 1

  • Dose: 0.5-1 mg IV, repeat as needed
  • For hemodynamically significant bradycardia
  • Caveat: Frequently ineffective, especially with severe toxicity

Extracorporeal Therapies

6. Hemodialysis for Atenolol 1, 5, 6

  • Specific indication: Atenolol is hydrophilic and dialyzable (unlike amlodipine which is highly protein-bound)
  • Consider early in severe atenolol poisoning with refractory shock
  • Continuous veno-venous hemodialysis (CVVHD) has been used successfully 7
  • Amlodipine is NOT effectively removed by dialysis due to high protein binding (98%)

7. VA-ECMO 1

  • For refractory cardiogenic shock despite maximal pharmacologic therapy
  • Survival rates up to 77% reported in CCB overdose
  • Should be considered early rather than as last resort

Adjunctive/Rescue Therapies

8. Methylene Blue 1

  • Specifically for refractory vasodilatory shock from amlodipine (dihydropyridine CCB)
  • Dose: 1-2 mg/kg IV over 30 minutes
  • Responses are mixed and may be transient
  • Acts as nitric oxide synthase inhibitor

9. Angiotensin II 8, 9

  • Emerging therapy for refractory shock, particularly when ACE inhibitors co-ingested
  • May be especially beneficial in combined amlodipine-atenolol overdose due to impaired compensatory RAAS activation
  • Dramatic hemodynamic improvement reported in case reports

10. Intravenous Lipid Emulsion (ILE) 1

  • NOT recommended - Class III (No Benefit) for beta-blocker poisoning
  • Large retrospective study found no benefit in CCB poisoning 1
  • Despite this, some case reports describe use 4

Therapies with Limited Evidence

Electrical pacing 1: May be reasonable for hemodynamically significant bradydysrhythmias, but often ineffective, particularly with complete AV block or vasodilatory shock

Monitoring Requirements

  • Continuous cardiac monitoring and blood pressure
  • Blood glucose every 15-30 minutes during HIET initiation
  • Serum potassium every 2-4 hours (risk of hypokalemia with HIET)
  • Ionized calcium if using high-dose calcium therapy
  • Lactate and acid-base status
  • Renal function (acute kidney injury common) 7, 4
  • Volume status (risk of pulmonary edema with aggressive fluids) 7, 10, 2

Key Clinical Pearls

Combination toxicity is worse: The synergistic effects of amlodipine (vasodilation, negative inotropy) and atenolol (bradycardia, negative inotropy) create profound cardiovascular collapse that is more refractory than either agent alone 7, 4, 3.

Timing matters: Don't wait for conventional therapies to fail before escalating to HIET and considering ECMO. Early aggressive management improves outcomes 7, 3.

Expect prolonged course: Amlodipine's long half-life means effects persist for days. Patients may require ICU support for 5-8 days 7, 4.

Beware fluid overload: These patients develop pulmonary edema easily, even with modest crystalloid volumes, due to increased capillary permeability and cardiac dysfunction 7, 10, 2.

References

Research

Amlodipine overdose.

The Annals of pharmacotherapy, 1997

Research

A Case of Life-threatening Amlodipine and Atenolol Overdose.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2019

Research

Successful treatment of refractory hypotension, noncardiogenic pulmonary edema and acute kidney injury after an overdose of amlodipine.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.